Clinical Trial

Amphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference

RANCHO CUCAMONGA, CA / ACCESSWIRE / August 31, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO…

10 months ago

Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference

ANN ARBOR, MI / ACCESSWIRE / August 31, 2023 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care…

10 months ago

Aimee DeGaetano Joins Vastrax as Global Head of Commercial and Clinical Affairs

Leading Clinical Research Organization Strengthens Expertise in Neurovascular FieldANDOVER, Mass.--(BUSINESS WIRE)--Vastrax, a premier full-service Contract Research Organization (CRO) with a…

10 months ago

Sickle Cell Warrior Program from The National Marrow Donor Program® (NMDP)/Be The Match® Expands Access to Bone Marrow Transplant as a Curative Treatment

During Sickle Cell Awareness Month, NMPD/Be The Match reminds individuals to visit SickleCellConnect.com to access essential resources, learn more about…

10 months ago

Biomea Fusion Announces Appointment of Juan Pablo Frías, M.D. as Chief Medical Officer

Industry veteran and prominent diabetes clinical development expert to oversee Biomea’s progressing clinical development of novel covalent menin inhibitor BMF-219…

10 months ago

Femasys Inc. Obtains Medical Device Establishment License from Health Canada

ATLANTA, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs…

10 months ago

Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference

SAN FRANCISCO, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing…

10 months ago

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ERIN CARTER TO BOARD OF DIRECTORS

Rutherford, NJ, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company…

10 months ago

BriaCell Accepts Letter of Intent from Weill Cornell Medicine Outlining Plans to Initiate a Clinical Trial of Bria-IMT™ in High-Risk Early-Stage Triple Negative Breast Cancer

PHILADELPHIA and VANCOUVER, British Columbia, Aug. 31, 2023 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell”…

10 months ago

Peak Bio, Inc., Announces Appointment of Michael Friedman to Board of Directors

Pleasanton, CA, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Peak Bio, Inc. ("Peak Bio" or the "Company") (OTC PK: PKBO), is a…

10 months ago